We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NMRA market cap is 1.4B. The company's latest EPS is USD -1.4789 and P/E is -5.90.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -56.86M | -114M | -60.07M |
| Net Income | -53.03M | -108.73M | -53.72M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -237.32M | -135.87M | -252.1M |
| Net Income | -237.31M | -130.9M | -235.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 544.75M | 496.2M | 450.21M |
| Total Liabilities | 32.06M | 27.12M | 25.67M |
| Total Equity | 512.69M | 469.08M | 424.54M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 429.3M | 426.23M | 496.2M |
| Total Liabilities | 24.66M | 29.4M | 27.12M |
| Total Equity | -325.22M | -446.85M | 469.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -111.84M | -163.28M | -42.96M |
| Investing | 50.71M | 64.39M | -150M |
| Financing | 232.42M | 231.94M | 1.85M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -75.42M | -114.9M | -163.28M |
| Investing | -817k | -168.01M | 64.39M |
| Financing | 293.51M | 115.74M | 231.94M |
| Market Cap | 1.4B |
| Price to Earnings Ratio | -5.90 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.72 |
| Price to Book Ratio | 2.97 |
| Dividend Yield | - |
| Shares Outstanding | 159.52M |
| Average Volume (1 week) | 1.03M |
| Average Volume (1 Month) | 594.14k |
| 52 Week Change | -46.97% |
| 52 Week High | 21.00 |
| 52 Week Low | 8.59 |
| Spread (Intraday) | 0.25 (2.78%) |
| Company Name | Neumora Therapeutics Inc |
| Address |
1209 orange street new castle, delaware |
| Website | https://www.neumoratx.com. |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
